Belgravia Hartford Closes USD $5M Convertible Debenture with Round13 Digital Asset Fund to Acquire Bitcoin
Belgravia Hartford closes USD $5M convertible debenture to buy more Bitcoin
Share
The debenture bears interest at a rate of 4% per annum, accrued monthly and paid at the end of the term, and matures two years from the closing date. Both the principal amount and accrued interest are convertible into common shares of Belgravia at a price of CAD $0.71 per share, representing a 40% premium to the volume-weighted average trading price ('VWAP') of Belgravia's common shares for the seven consecutive days as announced on July 16, 2025.
There are no warrants, commission or finders fees associated with this financing.
Belgravia will deploy the entire USD $5M to increase its Bitcoin holding from the 40.77 it holds currently. A further announcement will be made upon the completion of the full USD $5M Bitcoin purchase.
Mehdi Azodi, President & CEO of Belgravia Hartford said 'During the last 60 days Belgravia has rapidly executed our initial Bitcoin strategy and delivered on our promise to commit 100% of the capital raised to buying Bitcoin. Our speed to deploying capital to buying Bitcoin will continue to be expedited to increase our growing Bitcoin Treasury. This financing marks a significant milestone for Belgravia as we continue to enhance our balance sheet and rapidly buy Bitcoin. The convertible debenture significantly reduces dilution given the convertible is priced at CAD $.71 and enables Belgravia to buy more Bitcoin than originally anticipated.'
In addition, the debenture includes a performance-triggered conversion feature:
If, at any time prior to the maturity date, the VWAP of Belgravia's common shares on the Canadian Securities Exchange equals or exceeds C$1.42, or 200% of the conversion price, for 20 consecutive trading days, then 20% of the then-outstanding principal (together with a proportionate amount of accrued and unpaid interest) shall automatically convert into common shares of the Company without further action required by Round13 DAF.
For legal disclaimers and more information, please visit www.blgvbtc.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Quanta Services Inc (PWR) Q2 2025 Earnings Call Highlights: Record Backlog and Strategic ...
Release Date: July 31, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Quanta Services Inc (NYSE:PWR) reported strong double-digit growth in revenue, adjusted EBITDA, and adjusted earnings per share for Q2 2025. The company announced a record backlog of $35.8 billion, indicating strong future business prospects. Quanta Services Inc (NYSE:PWR) acquired Dynamic Systems, enhancing its capabilities in mechanical, plumbing, and process infrastructure solutions. The company made a strategic investment in Bell Lumber and Pole Company, expanding its utility infrastructure equipment portfolio. Quanta Services Inc (NYSE:PWR) increased its full-year 2025 financial expectations for revenue, adjusted EBITDA, and adjusted EPS, reflecting confidence in future performance. Negative Points The regulatory environment remains variable, which could impact future operations and financial performance. There is potential for short-term noise and political impacts from legislative changes, such as the 'big beautiful bill'. The company faces challenges in managing the timing and execution of large projects, which could affect backlog and revenue recognition. There is uncertainty regarding the long-term outlook for renewables post-2027, as tax credits wind down. Quanta Services Inc (NYSE:PWR) is evaluating refinancing alternatives to maintain liquidity, indicating potential financial constraints. Q & A Highlights Warning! GuruFocus has detected 7 Warning Signs with ING. Q: Duke, with the current political climate and AI-related capital expenditures ramping up, how confident are you in Quanta's sequential backlog growth, especially with the incremental transmission bookings? A: Duke Austin, President and CEO: We are confident in our growth trajectory, with a history of 20% plus growth over the past decade. Our strategic acquisitions and investments in technology and infrastructure position us well for future growth, particularly in the AI and power demand sectors. Q: How has the increased workload affected your bidding process, and are you able to be more selective with projects? A: Duke Austin, President and CEO: We focus on providing long-term, programmatic solutions rather than just bidding on projects. Our self-perform capabilities and execution certainty allow us to engage in longer-term discussions and be selective in our project choices. Q: Can you elaborate on the strategic rationale behind the acquisition of Dynamic Systems and its fit into your broader strategy? A: Duke Austin, President and CEO: Dynamic Systems complements our existing capabilities with its advanced technology and craft-centric approach. It allows us to expand into new markets and provide comprehensive solutions, enhancing our ability to meet customer demands for certainty and speed. Q: With the ITC winding down by 2027, how are you managing renewables work, and what is your outlook for renewables post-2028? A: Duke Austin, President and CEO: We are seeing pull-ins on LNTPs and have customers who are well safe-harbored into the future. We remain optimistic about the long-term prospects of renewables, given their cost-effectiveness and speed to market. Q: How are you preparing for potential short-term slowdowns in renewables, and what are the potential synergies from the Dynamic Systems acquisition? A: Duke Austin, President and CEO: We have a fungible workforce that can be allocated across different segments, allowing us to manage slowdowns effectively. The acquisition of Dynamic Systems offers significant revenue synergies and opportunities to improve margins through integrated solutions. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
22 minutes ago
- Business Wire
Sky Harbour to Report Its Second Quarter 2025 Financial Results and Host Webcast Investor Call on August 12th, 2025
WEST HARRISON, N.Y.--(BUSINESS WIRE)--Sky Harbour Group Corporation (NYSE: SKYH, SKYH WS) ('SHG' or the 'Company'), an aviation infrastructure company building the first nationwide network of Home-Basing campuses for business aircraft, today announced that it will release its Second Quarter 2025 financial results and file its quarterly report on Form 10-Q with the SEC after market close on Tuesday, August 12th, 2025, and that it will host an investor webcast at 5:00 pm ET the same day. On the call, Sky Harbour will review quarterly financial results and provide a general business update. A question-and-answer session with Sky Harbour leadership will follow. Both the call and webcast are open to the general public. The webcast will be publicly available in the UPCOMING EVENTS section of the Company's investor relations website, A replay of the webcast will be available on the Company's website following the event. To join the webcast, please use the following link: For the audio-only conference call, please use the following participant details: North America Toll-Free: (888) 660-6739 North America Toll: (929) 203-0875 International Toll: +1(929) 203-0875 Conference ID: 3259957 If you have any questions or are interested in connecting with Sky Harbour leadership, please contact Investor Relations at investors@ About Sky Harbour Group Corporation Sky Harbour Group Corporation is an aviation infrastructure company developing the first nationwide network of Home-Basing campuses for business aircraft. The Company develops, leases and manages general aviation hangars across the United States. Sky Harbour's Home-Basing offering aims to provide private and corporate customers with the best physical infrastructure in business aviation, coupled with dedicated service tailored to based aircraft, offering the shortest time to wheels-up in business aviation. To learn more, visit Forward Looking Statements Certain statements made in this release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995, including statements about the expectations regarding future operations at Sky Harbour Corporation and its subsidiaries. When used in this press release, the words 'plan,' 'believe,' 'expect,' 'anticipate,' 'intend,' 'outlook,' 'estimate,' 'forecast,' 'project,' 'continue,' 'could,' 'may,' 'might,' 'possible,' 'potential,' 'predict,' 'should,' 'would' and other similar words and expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements are based on the current expectations of the management of Sky Harbour Group Corporation (the 'Company') as applicable and are inherently subject to uncertainties and changes in circumstances. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. For more information about risks facing the Company, see the Company's annual report on Form 10-K for the year ended December 31, 2024, and other filings the Company makes with the SEC from time to time. The Company's statements herein speak only as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Business Wire
22 minutes ago
- Business Wire
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems, Inc. (NASDAQ: KRMD) ('KORU Medical' or the 'Company'), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced inducement equity awards to Adam Kalbermatten, Chief Commercial Officer, pursuant to his previously announced employment agreement with the Company dated as of June 30, 2025. Mr. Kalbermatten was granted nonqualified stock options on August 1, 2025 to purchase 600,000 shares of the Company's common stock at an exercise price of $3.44 per share. In addition, on July 28, 2025, his start date, Mr. Kalbermatten received 300,000 restricted shares of the Company's common stock. Each of these awards are subject to vesting 25% on each anniversary of their grant date, subject to accelerated vesting and the other terms and conditions of the respective award agreements entered into between Mr. Kalbermatten and the Company. The Compensation Committee of the Company's Board of Directors approved the awards as an inducement material to Mr. Kalbermatten's employment in accordance with Nasdaq Listing Rule 5635(c)(4). About KORU Medical Systems KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The Freedom Syringe Infusion System (the 'Freedom System') currently includes the Freedom60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HigH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Pharma Services and Clinical Trials business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of customizing the Freedom System for clinical and commercial use across multiple drug categories. For more information, please visit
